Pregaben CR 82.5 mg (Tablet (Controlled Release))
Unit Price: ৳ 25.00 (3 x 10: ৳ 750.00)
Strip Price: ৳ 250.00
Medicine Details
Category | Details |
---|---|
Generic | Pregabalin |
Company | Incepta pharmaceuticals ltd |
Also available as |
Title
- Pregaben CR 82.5 mg Tablet
Categories
- Medicine
- Pharmaceuticals
- Neuropathic Pain Management
- Seizure Treatment
- Fibromyalgia Therapy
Description
- Pregaben CR 82.5 mg Tablet is an anticonvulsant
- First-line treatment for neuropathic pain, shingles, seizures, and fibromyalgia
- Route of administration: Oral, with or without food
- Must be swallowed whole and should not be split, crushed or chewed
- Should be administered after an evening meal
- Should not be discontinued abruptly
Dosage
- Recommended dosage for different conditions
- Maximum recommended doses for adults
- Dosing adjustments based on efficacy and tolerability
Mode of Action
- Structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA)
- Binds with high affinity to the alpha2-delta site in central nervous system tissues
- Mechanism of action not fully elucidated
Indications
- Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
- Postherpetic neuralgia (PHN)
- Partial-onset seizures in patients 1 month of age and older
- Fibromyalgia
- Neuropathic pain associated with spinal cord injury
Contraindications
- Contraindicated in patients with known hypersensitivity to Pregabalin or any of its components
Interaction
- Unlikely to be involved in significant pharmacokinetic drug interactions
- No significant interactions with food or others
Side Effects
- Common side effects in adults: dizziness, somnolence, dry mouth, edema, blurred vision, weight gain, thinking abnormal
- Common side effects in pediatric patients: increased weight, increased appetite
Pregnancy & Lactation
- No adequate and well-controlled studies in pregnant women
- Small amounts detected in the milk of lactating women
- Breastfeeding not recommended due to potential risk of tumorigenicity
Precautions & Warnings
- Angioedema can occur and may be life-threatening, discontinue immediately
- Discontinue immediately if hypersensitivity reactions occur
- Increased risk of suicidal thoughts or behavior
- Respiratory depression may occur when used with concomitant CNS depressants
Use in Special Populations
- Safety and effectiveness not established in pediatric patients for various conditions
Overdose Effects
- Signs and symptoms of overdose
- No specific antidote
- General supportive care indicated
Therapeutic Class
- Adjunct anti-epileptic drugs
- Primary anti-epileptic drugs
Storage Conditions
- Keep in a cool & dry place (below 30°C)
- Protected from light & moisture
- Keep out of the reach of children
Chemical Structure
- Molecular formula: C8H17NO2
- Chemical Structure: Image available
Commonly Asked Questions
- Information about Pregaben CR 82.5 mg Tablet
- Frequency, storage, and disposal instructions
- Dosage frequency
- Use with other medications
- Potential weight gain
- Quick tips for usage
Related Brands
- Nerfid 150 mg (Capsule) - the-white-horse-pharmaceuticals-ltd
- Nerfid 25 mg (Capsule) - the-white-horse-pharmaceuticals-ltd
- Pregaba ER 330 mg (Tablet (Extended Release)) - opsonin-pharma-ltd
- Pregaba ER 165 mg (Tablet (Extended Release)) - opsonin-pharma-ltd
- Pregaba ER 82.5 mg (Tablet (Extended Release)) - opsonin-pharma-ltd